• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 2,3-二苯基苯并[g]喹喔啉的近红外发射杂环阳离子铱配合物作为体外诊断与治疗的光动力治疗试剂。

Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.

机构信息

Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, USA.

出版信息

Dalton Trans. 2017 Jun 27;46(25):8091-8103. doi: 10.1039/c7dt00913e.

DOI:10.1039/c7dt00913e
PMID:28604869
Abstract

Five heteroleptic cationic iridium complexes with a π-expansive cyclometalating 2,3-diphenylbenzo[g]quinoxaline (dpbq) ligand (C^N ligand) and different diimine ligands (N^N ligands) (i.e. 2,2'-bipyridine (bpy, 1), phenanthroline (phen, 2), 2-(2-pyridinyl)quinoline (pqu, 3), 2,2'-bisquinoline (bqu, 4), and 2-(quinolin-2-yl)quinoxaline (quqo, 5)) were synthesized and characterized. The lowest-energy singlet electronic transitions (S states) were mainly dpbq ligand-centred ILCT (intraligand charge transfer)/MLCT (metal to ligand charge transfer) transitions mixed with some π,π* transitions for complexes 1-4 with increased contributions from LLCT (ligand to ligand charge transfer) in 3 and 4. For complex 5, the S state was switched to the LLCT/MLCT transitions. All five complexes displayed weak near-infrared (NIR) phosphorescence, with maximal emission output spanning 700-1400 nm and quantum yields being on the order of 10. The triplet state absorptions of 1-4 all resembled that of the [Ir(dpbq)Cl] dimer with lifetimes of ca. 400 ns, while the TA spectrum of 5 possessed the characteristics of both the quqo ligand and the [Ir(dpbq)Cl] dimer with a bi-exponential decay of ca. 5 μs and 400 ns. While the photophysics of these complexes differ slightly, their theranostic photodynamic therapy (PDT) effects varied drastically. All of the complexes were biologically active toward melanoma cells. Complexes 2 and 3 were the most cytotoxic, with 230-340 nM activity and selectivity factors for melanoma cells over normal skin fibroblasts of 34 to 40 fold. Complexes 2, 3, and 5 became very potent cytotoxins with light activation, with EC values as low as 12-18 nM. This potent nanomolar light-triggered activity combined with a lower dark toxicity resulted in 5 having a phototherapeutic index (PI) margin of almost 275. The bpy coligand led to the least amount of dark toxicity of 1, while phen and pqu produced cytotoxic but selective complexes 2 and 3. The quqo coligand produced the most potent complex 5 for in vitro PDT, both in terms of photocytotoxicity and PI. All Ir(iii) complexes exhibited very bright NIR phosphorescence in melanoma cells. The wide range of cytotoxicity and photocytotoxicity effects within a relatively small class of complexes highlights the importance of the identity of the coligand in the biological activity of the π-expansive biscyclometalated Ir(iii) complexes, and their bright NIR emission in live cells demonstrates their potential as theranostic PDT agents.

摘要

五种具有π扩展的环金属化 2,3-二苯基苯并[g]喹喔啉(dpbq)配体(C^N 配体)和不同二亚胺配体(N^N 配体)的异核阳离子铱配合物(即 2,2'-联吡啶(bpy,1)、菲咯啉(phen,2)、2-(2-吡啶基)喹啉(pqu,3)、2,2'-联喹啉(bqu,4)和 2-(喹喔啉-2-基)喹喔啉(quqo,5))被合成并进行了表征。最低能量单重电子跃迁(S 态)主要是 dpbq 配体中心的 ILCT(配体内电荷转移)/MLCT(金属到配体电荷转移)跃迁,同时对于 3 和 4 中的配合物,还混合了一些π,π*跃迁,LLCT(配体到配体电荷转移)的贡献增加。对于配合物 5,S 态被切换到 LLCT/MLCT 跃迁。所有五种配合物都显示出微弱的近红外(NIR)磷光,最大发射输出范围为 700-1400nm,量子产率约为 10%。1-4 的三重态吸收均类似于[Ir(dpbq)Cl]二聚体,寿命约为 400ns,而 5 的 TA 光谱具有 quqo 配体和[Ir(dpbq)Cl]二聚体的特征,具有约 5μs 和 400ns 的双指数衰减。尽管这些配合物的光物理性质略有不同,但它们的治疗性光动力疗法(PDT)效果却有很大的不同。所有配合物对黑色素瘤细胞均具有生物活性。配合物 2 和 3 的细胞毒性最强,对黑色素瘤细胞的活性为 230-340 nM,对正常皮肤成纤维细胞的选择性因子为 34-40 倍。配合物 2、3 和 5 在光激活后成为非常有效的细胞毒素,EC 值低至 12-18 nM。这种强大的纳米摩尔光触发活性与较低的暗毒性相结合,使 5 的光治疗指数(PI)差值接近 275。bpy 共聚配体导致 1 的暗毒性最小,而 phen 和 pqu 产生了具有细胞毒性但选择性的配合物 2 和 3。quqo 共聚配体产生了最有效的用于体外 PDT 的配合物 5,无论是在光细胞毒性还是 PI 方面。所有 Ir(iii)配合物在黑色素瘤细胞中均表现出非常明亮的近红外磷光。在相对较小的一类配合物中,细胞毒性和光细胞毒性的广泛范围突出了共聚配体在π扩展双环金属化 Ir(iii)配合物生物活性中的重要性,它们在活细胞中的明亮近红外发射证明了它们作为治疗性光动力疗法 PDT 试剂的潜力。

相似文献

1
Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.基于 2,3-二苯基苯并[g]喹喔啉的近红外发射杂环阳离子铱配合物作为体外诊断与治疗的光动力治疗试剂。
Dalton Trans. 2017 Jun 27;46(25):8091-8103. doi: 10.1039/c7dt00913e.
2
π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.作为光动力疗法的反向饱和吸收剂和光敏剂的π-扩展异核钌(II)配合物
Inorg Chem. 2017 Mar 20;56(6):3245-3259. doi: 10.1021/acs.inorgchem.6b02624. Epub 2017 Mar 6.
3
Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.带有噻吩基的 π-扩展环金属化配体的钌(II)配合物的光物理性质和光生物活性。
Inorg Chem. 2019 Aug 19;58(16):10778-10790. doi: 10.1021/acs.inorgchem.9b01044. Epub 2019 Aug 6.
4
Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.含 BODIPY 取代的 N-杂环卡宾 (NHC) 配体的中性铱 (III) 配合物:合成、光物理、体外治疗光动力疗法和抗菌活性。
Photochem Photobiol Sci. 2019 Oct 9;18(10):2381-2396. doi: 10.1039/c9pp00142e.
5
Heteroleptic Ir(III)N Complexes with Long-Lived Triplet Excited States and in Vitro Photobiological Activities.具有长寿命三重态激发态和体外光生物活性的杂配 Ir(III)N 配合物。
ACS Appl Mater Interfaces. 2019 Jan 30;11(4):3629-3644. doi: 10.1021/acsami.8b14744. Epub 2019 Jan 17.
6
Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.双核铱(III)双三齿配合物的光物理和光生物性质。
Inorg Chem. 2018 Aug 20;57(16):9859-9872. doi: 10.1021/acs.inorgchem.8b00789. Epub 2018 Aug 9.
7
Multinuclear 2-(Quinolin-2-yl)quinoxaline-Coordinated Iridium(III) Complexes Tethered by Carbazole Derivatives: Synthesis and Photophysics.由咔唑衍生物连接的多核2-(喹啉-2-基)喹喔啉配位铱(III)配合物:合成与光物理性质
Inorg Chem. 2020 Dec 7;59(23):17096-17108. doi: 10.1021/acs.inorgchem.0c02366. Epub 2020 Nov 10.
8
Tuning the Photophysics and Reverse Saturable Absorption of Heteroleptic Cationic Iridium(III) Complexes via Substituents on the 6,6'-Bis(fluoren-2-yl)-2,2'-biquinoline Ligand.通过6,6'-双(芴-2-基)-2,2'-联喹啉配体上的取代基调节杂配阳离子铱(III)配合物的光物理性质和反饱和吸收
Inorg Chem. 2016 Nov 21;55(22):11908-11919. doi: 10.1021/acs.inorgchem.6b02028. Epub 2016 Nov 7.
9
Photophysics and reverse saturable absorption of cationic dinuclear iridium(III) complexes bearing fluorenyl-tethered 2-(quinolin-2-yl)quinoxaline ligands.含芴基连接的2-(喹啉-2-基)喹喔啉配体的阳离子双核铱(III)配合物的光物理性质及反饱和吸收
Dalton Trans. 2021 Oct 19;50(40):14309-14319. doi: 10.1039/d1dt02176a.
10
Synthesis and photophysics of reverse saturable absorbing heteroleptic iridium(III) complexes bearing 2-(7-R-fluoren-2'-yl)pyridine ligands.含有 2-(7-R-芴-2'-基)吡啶配体的反饱和吸收杂环铱(III)配合物的合成与光物理性质。
Dalton Trans. 2014 Jan 28;43(4):1724-35. doi: 10.1039/c3dt52184b.

引用本文的文献

1
A Novel Substituted Benzo[]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.一种新型的基于苯并[]喹喔啉取代的环金属化钌(II)配合物作为生物相容性膜靶向光动力疗法结肠癌干细胞剂。
J Med Chem. 2024 Dec 12;67(23):21470-21485. doi: 10.1021/acs.jmedchem.4c02357. Epub 2024 Dec 2.
2
Ir(III) Half-Sandwich Photosensitizers with a π-Expansive Ligand for Efficient Anticancer Photodynamic Therapy.具有π-扩展配体的 Ir(III) 半三明治光增敏剂用于高效的抗癌光动力治疗。
J Med Chem. 2024 Feb 8;67(3):1783-1811. doi: 10.1021/acs.jmedchem.3c01276. Epub 2024 Jan 30.
3
Recent Advances in Organometallic NIR Iridium(III) Complexes for Detection and Therapy.
近十年金属有机近红外铱(III)配合物用于检测和治疗的研究进展
Molecules. 2024 Jan 3;29(1):256. doi: 10.3390/molecules29010256.
4
Investigation of the N^C Ligand Effects on Emission Characteristics in a Series of Bis-Metalated [Ir(N^C)(N^N)] Complexes.研究一系列双金属化[Ir(N^C)(N^N)]配合物中 N^C 配体对发射特性的影响。
Molecules. 2023 Mar 17;28(6):2740. doi: 10.3390/molecules28062740.
5
Recent advances in noble metal complex based photodynamic therapy.基于贵金属配合物的光动力疗法的最新进展
Chem Sci. 2022 Apr 1;13(18):5085-5106. doi: 10.1039/d1sc05478c. eCollection 2022 May 11.
6
BSA-encapsulated cyclometalated iridium complexes as nano-photosensitizers for photodynamic therapy of tumor cells.牛血清白蛋白包裹的环金属化铱配合物作为用于肿瘤细胞光动力治疗的纳米光敏剂。
RSC Adv. 2021 Apr 23;11(25):15323-15331. doi: 10.1039/d1ra01740c. eCollection 2021 Apr 21.
7
Near-infrared emitting iridium complexes: Molecular design, photophysical properties, and related applications.近红外发光铱配合物:分子设计、光物理性质及相关应用。
iScience. 2021 Jul 17;24(8):102858. doi: 10.1016/j.isci.2021.102858. eCollection 2021 Aug 20.
8
Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.含 BODIPY 取代的 N-杂环卡宾 (NHC) 配体的中性铱 (III) 配合物:合成、光物理、体外治疗光动力疗法和抗菌活性。
Photochem Photobiol Sci. 2019 Oct 9;18(10):2381-2396. doi: 10.1039/c9pp00142e.
9
Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.带有噻吩基的 π-扩展环金属化配体的钌(II)配合物的光物理性质和光生物活性。
Inorg Chem. 2019 Aug 19;58(16):10778-10790. doi: 10.1021/acs.inorgchem.9b01044. Epub 2019 Aug 6.
10
Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.双核铱(III)双三齿配合物的光物理和光生物性质。
Inorg Chem. 2018 Aug 20;57(16):9859-9872. doi: 10.1021/acs.inorgchem.8b00789. Epub 2018 Aug 9.